Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Esophageal Squamous Carcinoma Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07272291
What this trial is testing

A Phase II Study of Toripalimab Plus Chemotherapy and Low-Dose Radiotherapy for Neoadjuvant Therapy-Refractory Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Tianjin Medical University Cancer Institute and Hospital 48
Not applicableAvailableNCT05974410
What this trial is testing

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

Who this might be right for
GlioblastomaSquamous Cell CarcinomaHodgkin Lymphoma+14 more
AVM Biotechnology Inc
Testing effectiveness (Phase 2)Looking for participantsNCT06975410
What this trial is testing

Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors

Who this might be right for
EGFR OverexpressionLocally Advanced Solid TumorMetastatic Solid Tumor
Yuhan Corporation 80
Early research (Phase 1)Looking for participantsNCT06545331
What this trial is testing

Study of XB010 in Subjects With Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid TumorsEsophageal Squamous Cell CancerHead and Neck Squamous Cell Cancer+3 more
Exelixis 396
Testing effectiveness (Phase 2)Study completedNCT02423811
What this trial is testing

Fursultiamine in Esophageal Squamous Cell Carcinoma Patients Who Receive Concurrent Chemoradiotherapy

Who this might be right for
Cancer Stem Cell
National Cheng-Kung University Hospital 20
Not applicableStudy completedNCT04161781
What this trial is testing

PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer

Who this might be right for
Esophagogastric CancerEsophagus CancerEsophageal Cancer+4 more
Memorial Sloan Kettering Cancer Center 10
Large-scale testing (Phase 3)Study completedNCT02813967
What this trial is testing

S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal Cancer

Who this might be right for
Esophageal CancerChemoradiation
Zhejiang Cancer Hospital 298
Not applicableStudy completedNCT03404921
What this trial is testing

Efficacy and Safety of Endoscopic Submucosal Tunnel Dissection for Superficial Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Superficial Mucosal Lesion
Xijing Hospital of Digestive Diseases 160
Early research (Phase 1)Study completedNCT00601692
What this trial is testing

Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Memorial Sloan Kettering Cancer Center 27
Testing effectiveness (Phase 2)Looking for participantsNCT06637163
What this trial is testing

Benmelstobart Combined With Radiochemotherapy as Neoadjuvant Treatment Iin ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital 100
Not applicableUnknownNCT01151839
What this trial is testing

A Trial to Compare Preoperative Chemoradiation and Surgery Versus Surgery Alone in Squamous Cell Carcinoma of Oesophagus

Who this might be right for
Esophageal Neoplasms
All India Institute of Medical Sciences 100
Testing effectiveness (Phase 2)UnknownNCT04866381
What this trial is testing

An Exploratory Clinical Study of SHR6390 and SHR1020 in the Treatment of Esophageal Squamous Cell Carcinoma After Progression on PD-1 Antibody

Who this might be right for
Esophageal Squamous Cell CarcinomaProgression to PD-1 Antibody
Tianjin Medical University Cancer Institute and Hospital 87
Not applicableStudy completedNCT06241066
What this trial is testing

The Prognostic Value of Tertiary Lymphatic Structure in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 359
Testing effectiveness (Phase 2)Looking for participantsNCT05473156
What this trial is testing

Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected Malignancies

Who this might be right for
Locally Advanced or Metastatic Solid TumorsNon Small Cell Lung Cancer (NSCLC)Head and Neck Squamous Cell Carcinoma (HNSCC)+1 more
AP Biosciences Inc. 168
Large-scale testing (Phase 3)Looking for participantsNCT04415853
What this trial is testing

Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer

Who this might be right for
Esophageal Cancer
Sunshine Lake Pharma Co., Ltd. 416
Testing effectiveness (Phase 2)UnknownNCT03377400
What this trial is testing

Definitive CCRT Combined With Durvalumab and Tremelimumab for Inoperable Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Samsung Medical Center 40
Not applicableUnknownNCT06125262
What this trial is testing

Trajectory Analysis of NLR and Its Association With Efficacy of Immunochemotherapy in ESCC.

Who this might be right for
Esophageal Squamous Cell CarcinomaImmunotherapyChemotherapy
Guangdong Provincial People's Hospital 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07524374
What this trial is testing

SHR-1701 in Combination With Irinotecan Liposome (II) for Second-line Treatment of ESCC After Immunotherapy

Who this might be right for
ESCC
Zhigang Li 33
Testing effectiveness (Phase 2)Looking for participantsNCT06646588
What this trial is testing

Fruquintinib in Combination With Tislelizumab Followed by Radiotherapy in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Neoplasms
Hebei Medical University Fourth Hospital 67
Testing effectiveness (Phase 2)Active Not RecruitingNCT01142388
What this trial is testing

Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Metastatic Esophageal AdenocarcinomaMetastatic Esophageal Squamous Cell CarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma+5 more
National Cancer Institute (NCI) 94
Next Page